학술논문
An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
Document Type
Article
Author
Source
In: Gut . (Gut, 1 May 2003, 52(5):671-676)
Subject
Language
English
ISSN
00175749